title: Use of acetylcholine mustard to study allosteric interactions at the M(2) muscarinic receptor.
abstract: We explored the interaction of a nitrogen mustard derivative of acetylcholine with the human M(2) muscarinic receptor expressed in Chinese hamster ovary cells using the muscarinic radioligand, [3H]N-methylscopolamine (NMS). Acetylcholine mustard caused a concentration-dependent, first-order loss of [3H]NMS binding at 37 degrees C, with the half-maximal rate constant occurring at 24 microM and a maximal rate constant of 0.16 min(-1). We examined the effects of various ligands on the rate of alkylation of M(2) receptors by acetylcholine mustard. N-methylscopolamine and 4-(trimethylamino)-2-butynyl-(3-chlorophenyl)carbamate (McN-A-343) competitively slowed the rate of alkylation, whereas the inhibition by gallamine reached a plateau at high concentrations, indicating allosteric inhibition. In contrast, 17-beta-hydroxy-17-alpha-ethynyl-5-alpha-androstano[3,2-beta]-pyrimido[1,2-alpha]benzimidazole (WIN 51708) had no effect. We also measured the inhibition of [3H]NMS binding by acetylcholine mustard at 0 degrees C, conditions under which there is little or no detectable covalent binding. In these experiments, the dissociation constant of the aziridinium ion of acetylcholine mustard was estimated to be 12.3 microM. In contrast, the parent mustard and alcoholic hydrolysis product of acetylcholine mustard were without effect. Our results show that measurement of the effects of ligands on the rate of inactivation of the orthosteric site by a small site-directed electrophile is a powerful method for discriminating competitive inhibition from allosterism.
authors.affiliation: Department of Pharmacology, School of Medicine, University of California, Irvine, Irvine, CA 92697-4625, USA.
authors.forename: Hinako
authors.initials: H
authors.lastname: Suga
authors.forename: Katherine W
authors.initials: KW
authors.lastname: Figueroa
authors.forename: Frederick J
authors.initials: FJ
authors.lastname: Ehlert
mesh_terms: D008455:(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride / Q000494:pharmacology; D000109:Acetylcholine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000478:Alkylation; D000494:Allosteric Regulation; D000731:Androstanes / Q000494:pharmacology; D000818:Animals; D001562:Benzimidazoles / Q000494:pharmacology; D001667:Binding, Competitive; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D005703:Gallamine Triethiodide / Q000494:pharmacology; D006801:Humans; D019832:N-Methylscopolamine / Q000378:metabolism; D043585:Receptor, Muscarinic M2 / Q000378:metabolism*
chemical_list: D000731:Androstanes; D001562:Benzimidazoles; D043585:Receptor, Muscarinic M2; C086111:WIN 51708; C002561:acetylcholine mustard; D008455:(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; D000109:Acetylcholine; D005703:Gallamine Triethiodide; D019832:N-Methylscopolamine